3011
Is Immunotherapy Getting Safer? Updated Information on Various Forms of Immunotherapy and How to Improve
Sunday, March 2, 2014: 7:00 AM-8:00 AM
Marriott South Tower, Level 1, Solana
1.00 CME/ 1.20 CE
Primary Discussion Leaders:
Tolly Epstein , MD MS
Michael S. Tankersley , MD FAAAAI
Learning Objectives:
  1. Summarize current evidence regarding the incidence of fatal reactions to SCIT
  2. Critically assess new evidence characterizing risk factors associated with SCIT anaphylaxis that may be applied to optimize safety protocols
  3. Discuss the necessity of thirty minute waiting period after SCIT injections
See more of: Seminar